Post Profile

In vitro and ex vivo strategies for intracellular delivery

Intracellular delivery of materials has become a critical component of genome-editing approaches, ex vivo cell-based therapies, and a diversity of fundamental research applications. Limitations of current technologies motivate development of next-generation systems that can deliver a broad variety of cargo to diverse cell types.
read more


Related Posts

A new player in appetite control

Health : EurekAlert: Health

(Massachusetts Institute of Technology) MIT neuroscientists have discovered brain cells called glial cells play a critical role in controlling appetite and feeding. In a study of mice, the researchers found these cells stimulate ove...

Genomic testing could speed research on skin disease, bring new drugs to patients faster

Health : EurekAlert: Health

(Rockefeller University) When a person suffering from psoriasis starts taking a new therapy, it can currently take months to assess if the drug is working. But according to a recent study, that process could be significantly sped up...

Genome Editing, a Next Step in Genetic Therapy, Corrects Hemophilia in Animals

Health : Newswise Medical News

Using an innovative, precise gene therapy tool called genome editing, scientists treated the blood clotting disorder hemophilia in mice. It's the first time in vivo genome editing has achieved clinically meaningful results.

Vitro Announces Application Of Its Stem Cell Technology To Cancer Research & Treatment Files New Patent Application

Health : Medical News Today

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced advances in its adult stem cell research indicating application of its technology and stem cell lines to cancer research and treatment. Cancer stem cells may gene...

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

Academics : Nature AOP

S63845 specifically inhibits MCL1 and induces tumour cell death in vitro and in vivo in diverse cancer-derived cell lines with an acceptable safety margin.


Copyright © 2016 Regator, LLC